Skip to main content
SpringerLink
Log in

Belimumab

Infections, bladder cancer and possible demyelinating syndrome: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fanouriakis A, et al. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. Seminars in Arthritis and Rheumatism 48: 467-474, No. 3, Dec 2018. Available from: URL: http://doi.org/10.1016/j.semarthrit.2018.02.014 -Greece

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Belimumab. Reactions Weekly 1737, 61 (2019). https://doi.org/10.1007/s40278-019-57156-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-57156-5

Search

Navigation